A strategic partnership between Vaxxas and Profenso, an Australian AI company specialising in advanced automation for ...
Chongwei Shi Advances Genetic Research Through DNA Microarray Technology Principles and Applications
A recent study on DNA microarray technology highlights its essential role in enabling high-throughput analysis of large numbers of genes through arrays of probes integrated on a solid-phase support.
Pimple patches seem to be soaring in popularity—and a newly invented type that makes zits disappear without pain or irrtitation in mere days could soon be all the rage. Researchers have created a ...
Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via “patch” technology and utilizes Micron’s first-in-class dissolvable microarray technology Research builds on Emory’s ...
Atlanta (June 16 2025)-- Emory University and Micron Biomedical today announced the first clinical trial of a novel rotavirus vaccine, CC24, delivered via dissolvable microarray technology, is now ...
The COVID-19 pandemic highlighted significant vulnerabilities in global vaccine distribution. Traditional methods face challenges such as the need for refrigeration and trained administrators, ...
Reported Data Supports the Potential Extension of HD-MAP Vaccine Delivery to Oncology Indications Recently published data generated by researchers at The University of Queensland and Vaxxas shows ...
[Image from Micron Biomedical website] Micron Biomedical announced today that it added $16 million in funding to bring its Series A equity round to more than $33 million. J2 Ventures and the Global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results